Robert Niecestro
General Counsel bei THARIMMUNE, INC.
Profil
Robert Niecestro is the founder of Axsome Therapeutics, Inc. which was founded in 2012.
He held the title of Vice President-Clinical & Regulatory.
Currently, he is the Managing Director at AccelaPHARM LLC and the Head-Regulatory Affairs at Tharimmune, Inc. He previously worked as a Senior Director-Clinical Development at Eisai, Inc., Director-Clinical Operations at Organon USA, Inc., Executive Vice President-Clinical & Regulatory at TG Therapeutics, Inc., Vice President-Clinical & Regulatory Affairs at Keryx Biopharmaceuticals, Inc., and Vice President-Clinical Development at Andrx Laboratories, Inc. Dr. Niecestro received his undergraduate degree from the University of Illinois.
Aktive Positionen von Robert Niecestro
| Unternehmen | Position | Beginn |
|---|---|---|
| THARIMMUNE, INC. | General Counsel | - |
| AccelaPHARM LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Robert Niecestro
| Unternehmen | Position | Ende |
|---|---|---|
| KERYX BIOPHARMACEUTICALS | Corporate Officer/Principal | - |
| Organon USA, Inc. | Corporate Officer/Principal | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | - |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Andrx Laboratories, Inc. was a specialty pharmaceuticals company that was acquired by Watson Pharmaceuticals in November 2006. It engaged in the development and commercialization of controlled-release branded pharmaceuticals and generics. The company was founded in 1995 and was headquartered in Fort Lauderdale, FL. | Corporate Officer/Principal | - |
| AXSOME THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Robert Niecestro
| University of Illinois | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| AXSOME THERAPEUTICS, INC. | Health Technology |
| THARIMMUNE, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
| Organon USA, Inc. | |
Andrx Laboratories, Inc.
Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Andrx Laboratories, Inc. was a specialty pharmaceuticals company that was acquired by Watson Pharmaceuticals in November 2006. It engaged in the development and commercialization of controlled-release branded pharmaceuticals and generics. The company was founded in 1995 and was headquartered in Fort Lauderdale, FL. | Health Technology |
| AccelaPHARM LLC |
